Cargando…

Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls

Detalles Bibliográficos
Autores principales:	Rootman, Joseph M., Kiraga, Maggie, Kryskow, Pamela, Harvey, Kalin, Stamets, Paul, Santos-Brault, Eesmyal, Kuypers, Kim P. C., Walsh, Zach
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334589/ https://www.ncbi.nlm.nih.gov/pubmed/35902723 http://dx.doi.org/10.1038/s41598-022-17428-0

Ejemplares similares

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
por: Rootman, Joseph M., et al.
Publicado: (2021)

Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
por: Cavanna, Federico, et al.
Publicado: (2022)

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)

The therapeutic potential of microdosing psychedelics in depression
por: Kuypers, Kim P.C.
Publicado: (2020)

The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study
por: Kinderlehrer, Daniel A
Publicado: (2023)

Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study
por: van Elk, Michiel, et al.
Publicado: (2021)

Motives and Side-Effects of Microdosing With Psychedelics Among Users
por: Hutten, Nadia R P W, et al.
Publicado: (2019)

Microdosing: Concept, Application and Relevance
por: Tewari, Tushar, et al.
Publicado: (2010)

Asking questions of psychedelic microdosing
por: Cameron, Lindsay P
Publicado: (2021)

Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study
por: Marschall, Josephine, et al.
Publicado: (2021)

A systematic study of microdosing psychedelics
por: Polito, Vince, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Phase 0 - Microdosing strategy in clinical trials
por: Rani, P. Usha, et al.
Publicado: (2008)

Psychedelic microdosing benefits and challenges: an empirical codebook
por: Anderson, Thomas, et al.
Publicado: (2019)

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
por: Kuypers, Kim PC, et al.
Publicado: (2019)

Self-blinding citizen science to explore psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2021)

Buprenorphine Microdosing Cross Tapers: A Time for Change
por: Raheemullah, Amer, et al.
Publicado: (2022)

Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
por: Pasquale, Louis R, et al.
Publicado: (2018)

Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study
por: Haijen, Eline C. H. M., et al.
Publicado: (2023)

Disease Detection by Ultrasensitive Quantification of Microdosed Synthetic Urinary Biomarkers
por: Warren, Andrew D., et al.
Publicado: (2014)

A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012)

Microbial population dynamics under microdoses of the essential oil arborvitae
por: McGregor, Rhegan C., et al.
Publicado: (2019)

Powerful substances in tiny amounts: An interview study of psychedelic microdosing
por: Johnstad, Petter Grahl
Publicado: (2018)

Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series
por: Menard, Shannon, et al.
Publicado: (2022)

Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health
por: Ryan, Rebecca S., et al.
Publicado: (2023)

Subjective and Objective Measurements of the Facial Effects of Microdoses of Botulinum Toxin
por: Hexsel, Doris, et al.
Publicado: (2023)

Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
por: Cameron, Lindsay P., et al.
Publicado: (2019)

Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
por: Prochazkova, Luisa, et al.
Publicado: (2018)

Dose‐linearity of the pharmacokinetics of an intravenous [(14)C]midazolam microdose in children
por: van Groen, Bianca D., et al.
Publicado: (2019)

Intratarget Microdosing for Deep Phenotyping of Multiple Drug Effects in the Live Brain
por: Kim, Jennifer, et al.
Publicado: (2022)

Ibogaine microdosing in a patient with bipolar depression: a case report
por: Fernandes-Nascimento, Maria Helha, et al.
Publicado: (2022)

Automated Microdosing System for Integration With a Miniaturized High-pressure Reactor System
por: Stoll, Norbert, et al.
Publicado: (2005)

Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development
por: Burt, T, et al.
Publicado: (2016)

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
por: Kaertner, L. S., et al.
Publicado: (2021)

Microdosing and standard‐dosing take‐home buprenorphine from the emergency department: A feasibility study
por: Moe, Jessica, et al.
Publicado: (2020)

Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees
por: Kiraga, Maggie Kamila, et al.
Publicado: (2022)

Successful Use of [(14)C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism
por: Mooij, Miriam G., et al.
Publicado: (2017)

Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans
por: Elbe, Annika, et al.
Publicado: (2022)

Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
por: K. K., Adams, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0iel0tsdud9aenlm896kf8al6h